tirzepatide bimagrumab Lilly withdraws phase 2 obesity trial before starting enrollment tirzepatide bimagrumab Eli Lilly halts

While the body can synthesise small amounts of L-Carnitine from the amino acids lysine and methionine, this endogenous production may not always be sufficient especially for active individuals with higher energy demands

Protein shakes may cause nausea if they're too large, overly sweet, or thick in texture

Further Reading Why the Obesity Drug Revolution Is a Work in Progress GLP-1 weight-loss drugs like Wegovy and Zepbound are revolutionising obesity treatment and generating billions for their makers, but challenges including high costs, insurance coverage issues, drug shortages, and competition from copycats could impact their widespread success

San Mateo, California-based Mattson, a food and beverage product innovation firm that has worked with some high-profile foodtech startups as well as multinationals, is expanding to the Midwest with the acquisition of Chicago-based Hyde Park Group (HPG)